5
Growth Score
pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
261395
Vallon Pharmaceuticals is a clinical-stage biopharmaceutical company.
- David Baker: President & CEOPast Role: Alcobra Pharmaceuticals, Interim CEO
About the Company
Vallon Pharmaceuticals is a clinical-stage biopharmaceutical company. The Company is focused on the development of new medications to help patients with central nervous system (CNS) disorders. The Company’s lead investigational product candidate, ADAIR, is a novel abuse deterrent formulation of amphetamine immediate release being developed for the
treatment of ADHD and narcolepsy.
